secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcturus Therapeutics Holdings Inc. (ARCT)
CIK:        0001768224
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001193805-25-001734
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Andy Sassine to depart Dec 31, 2025; Controller Joe Roberts named interim CFO
--------------------------------------------------------------------------------

- CFO Andy Sassine and Arcturus mutually agreed to end employment effective Dec 31, 2025; he also resigned from the Board.
- Sassine receives severance: 12 months base salary ($572,000), bonus tied to CEO's 2025 bonus, 18 months COBRA, and full acceleration of 134,689 unvested stock options with 24-month exercise period.
- Joe Roberts, company Controller since March 2024, appointed interim principal financial and accounting officer; base salary $219,580, 20% target bonus.
- Board size reduced from nine to eight members effective immediately upon Sassine's resignation.
- Separation Agreement includes non-disparagement, standard release, and revocation period; severance contingent on release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768224/000119380525001734/0001193805-25-001734-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768224/000119380525001734/e665044_8k-arct.htm
  HTML page:      https://secwatch.observer/filing/0001193805-25-001734

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer